Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference58 articles.
1. Hesketh P, Navari R, Grote T, Gralla R, Hainsworth J, Kris M, et al. Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comp Chemother-Induc Emesis Prevent Group. 1996;14(8):2242–9.
2. Osoba D, Zee B, Pater J, Warr D, Latreille J. Kaizer LJJoCO. Determinants of postchemotherapy nausea and vomiting in patients with cancer. Qual Life Symptom Control Committees Nat Cancer Inst Canada Clin Trials Group. 1997;15(1):116–23.
3. Glare P, Miller J, Nikolova T, Tickoo RJCiia. Treating nausea and vomiting in palliative care: a review. 2011;6:243.
4. Chang VT, Hwang SS, Kasimis B, Thaler HTJCi. Shorter symptom assessment instruments: the condensed memorial symptom assessment scale (CMSAS). 2004;22(4):526-36.
5. Roila F, Hesketh PJ, Herrstedt JJAooojotESfMO. Prevention of chemotherapy-and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference. 2006;17(1):20-8.